// App-Quantinova.ai

: Patients? and physicians? preferences for treatment of anemia of chronic kidney disease: design methods of a discrete choice experiment

Researchers

Presenter

  • Ember Lu

Principal Investigators

  • Tony Okoro

  • Justyna Amelio

  • Christina Pao

  • Sebastian Heidenreich

  • Jaein Seo

  • Rodrigo Refoios Camejo

Medical Centers

  • R&D, GlaxoSmithKline, Collegeville, PA, United States,

  • 1Evidera Bethesda MD United States

  • Evidera, Inc., London, United Kingdom

  • GlaxoSmithKline, London, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Blood/haematological Diseases

Disease

  • Renal anemia

Biomarkers

  • 3β-hydroxysterol Δ24-reductase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved